Package Leaflets (PL) for Human medicinal products

The package leaflet (PL) provides users with information about the medicinal product and its correct use. The package leaflets contain instructions in both Finnish and Swedish.

The package leaflets can be searched from alphabetical list, with the name, marketing authorisation number and the Anatomical Therapeutic Chemical, i.e. ATC Code of the Summary of Product Characteristics, SPC.

The package leaflets processed as part of the EU centralised marketing authorisation procedure are published by the European Medicines Agency, EMA. Fimea's service contains links to the documents on medicinal products (EPAR PI) on the EMA website. Drugs belonging to the centralised authorisation procedure can be searched in Fimea's service by using an alphabetical list or by entering the product name or ATC code.

The material being published is not necessarily complete or up-to-date due to the technical quality of files submitted to the Finnish Medicines Agency Fimea or earlier to the National Agency for Medicines and the delays in delivery. For this reason, Fimea cannot guarantee that the document on the Internet fully complies with the summary of product characteristics and package leaflet officially approved by a desicion for a marketing authorisation. Only the hard copies of the SPCs and the PLs, which are in accordance with the marketing authorisation, are conclusive.

Product Information Leaflets 31 - 60 of 231
<  Previous 30    |  1  2  3  4  5  6  7  8  |  Next 30   >
SPC	Status for supply	Name of the medicinal product
SPC	Resepti	Valproat Life Medical 100 mg-ml injektio-infuusioneste, liuos PL 2022-01-14
SPC	Resepti	Valproat Sandoz 300 mg, 500 mg depottabletti PL 2024-04-22
SPC	Resepti	Valsarstad 160 mg tabletti, kalvopäällysteinen PL 2023-11-13
SPC	Resepti	Valsarstad 320 mg tabletti, kalvopäällysteinen PL 2023-11-13
SPC	Resepti	Valsarstad 40 mg tabletti, kalvopäällysteinen PL 2023-11-13
SPC	Resepti	Valsarstad 80 mg tabletti, kalvopäällysteinen PL 2023-11-13
SPC	Resepti	Valsartan Actavis 320 mg tabletti, kalvopäällysteinen PL 2023-05-11
SPC	Resepti	Valsartan Actavis 40 mg, 80 mg, 160 mg tabletti, kalvopäällysteinen PL 2023-05-11
SPC	Resepti	Valsartan Krka 320 mg tabletti, kalvopäällysteinen PL 2021-10-07
SPC	Resepti	Valsartan Krka 40 mg, 80 mg, 160 mg, tabletti, kalvopäällysteinen PL 2021-10-07
SPC	Resepti	Valsartan Sandoz 80 mg, 160 mg tabletti, kalvopäällysteinen PL 2022-06-21
SPC	Resepti	Valsartan-Hydrochlorothiazide Krka 80 mg-12.5 mg, 160 mg-12.5 mg, 160 mg-25 mg, 320 mg-12.5 mg, 320 mg-25 mg tabletti, kalvopäällysteinen PL 2023-09-01
SPC	Resepti	Valsartan-Hydrochlorothiazide Krka 80 mg-12.5 mg, 160 mg-12.5 mg, 160 mg-25 mg, 320 mg-12.5 mg, 320 mg-25 mg tabletti, kalvopäällysteinen PL 2023-09-01
SPC	Resepti	Valsartan-Hydrochlorothiazide Sandoz 80 mg-12.5 mg, 160 mg-12.5 mg tabletti, kalvopäällysteinen PL 2022-10-11
SPC	Resepti	Valsartan-Hydroklortiazid Actavis 320 mg-12.5 mg, 320 mg-25 mg tabletti, kalvopäällysteinen PL 2023-04-04
SPC	Resepti	Valsartan/Hydroklortiazid Actavis 80mg/12.5mg, 160mg/12.5mg, 160mg/25mg tabletti, kalvopäällysteinen PL 2023-05-11
SPC	Resepti	Valsartore Comp 80 mg-12,5 mg, 160 mg-12,5 mg, 160 mg-25 mg kalvopäällysteinen tabletti PL 2023-01-25
SPC	Resepti	Valtrex 250 mg, 500 mg tabletti, kalvopäällysteinen PL 2024-06-14
SPC	Resepti	Valtrex 250 mg, 500 mg tabletti, kalvopäällysteinen PL 2024-06-14
SPC	Resepti	Vaminolac infuusioneste, liuos PL 2020-07-15
SPC	Resepti	Vamtexar 500 mg-20 mg säädellysti vapauttavat tabletit PL 2024-09-25
SPC	Resepti	Vancomycin hameln 500 mg, 1000 mg kuiva-aine välikonsentraatiksi infuusionestettä varten, liuos PL 2024-07-12
SPC	Resepti	Vancomycin MIP Pharma 500 mg, 1000 mg infuusiokuiva-aine, liuosta varten PL 2020-12-15
SPC	Resepti	Vancomycin Orion 500 mg, 1000 mg kuiva-aine välikonsentraatiksi infuusionestettä varten, liuos PL 2024-03-12
SPC	Resepti	Vancomycin Strides 125 mg, 250 mg kapseli, kova PL 2021-10-20
SPC	Resepti	Vancomycin Xellia 125 mg, 250 mg kapseli, kova PL 2024-07-30
SPC	Resepti	Vancosan 500 mg, 1000 mg infuusiokuiva-aine, liuosta varten PL 2020-12-15
		European Medicines Agency's website: Vaniqa - EMA: EPAR PI Finnish Swedish
		European Medicines Agency's website: Vantavo (ent. Alendronate Sodium And Colecalciferol, MSD) - EMA: EPAR PI Finnish Swedish
SPC	Resepti	Vaqta 25 U-0.5 ml injektioneste, suspensio PL 2024-05-10
<  Previous 30    |  1  2  3  4  5  6  7  8  |  Next 30   >